Banking on Unity and China's orders
13/01/20 -"Elekta, a market leader in radiotherapy, is set to outgrow the industry in the mid-term – driven by potential pick-up in demand for its new linac (Unity) and expected orders from China. Moreover, ..."
Pages
59
Language
English
Published on
13/01/20
You may also be interested by these reports :
02/07/20
The increase in our NAV valuation is a result of an increase in our estimates, which is driven by the increased activity/focus in the vaccine space, ...
19/06/20
Elekta (Buy, Sweden), the world’s No.2 player (market share c.30%) in the $7.5bn oligopolistic radiation therapy oncology space, was dumped by ...
18/06/20
Benefiting from the gradual re-opening of economies, conditions within the hearing healthcare market have improved and Demant is now operating at a ...
09/06/20
Once the darling of COVID-19 lockdown times, the Health sector (ex Pharma) has gone into reverse now that the risk needle has moved by 180°. Sure ...